Where Einstein Meets Edison

Biotechnology Innovation: Emerging Opportunities in the Biologics/Biosimilar Market in the U.S.

Biotechnology Innovation: Emerging Opportunities in the Biologics/Biosimilar Market in the U.S.

Aug 12, 2010

“Generics” is a common term in the prescription drug business lexicon. Although generics market (Gx Market) sales have generally soared in recent years, the Gx market is predominant in countries with high healthcare expenditures. For example, in the US, healthcare expenditures reached over $2.2tn in 2007, accounting for 16% of GDP. Prescription medication...

The Story of a Successful Virus

The Story of a Successful Virus

Jun 1, 2010

The H1N1 09  Virus: The First Pandemic of the 21st Century. A historic announcement in April 2009 caused global panic and brought immediate attention to the state of public health.  The Mexican Secretariat of Health reported an outbreak of respiratory disease that was later classified as a novel swine origin influence A, H1N1 09.  The WHO quickly...